T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery

Conditions:   Breast Cancer;   Brain Metastasis;   Brain Cancer Interventions:   Drug: T-DM1;   Drug: TMZ Sponsor:   National Cancer Institute (NCI) Not yet recruiting - verified June 13, 2017 (Source: ClinicalTrials.gov)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2rzOX31
via IFTTT